The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 360 results:
Author Title Type [ Year(Asc)]
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
2017
Kountouras, C., Polyzos S. A., Stergiopoulos C., Katsinelos P., Tzivras D., Zavos C., et al. (2017).  A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke.. Sleep Med. 34, 256.
2016
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Triantafyllou G. Α., & Mantzoros C. S. (2016).  Activin A and follistatin in patients with nonalcoholic fatty liver disease.. Metabolism. 65(10), 1550-8.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2016).  Adipokines in nonalcoholic fatty liver disease.. Metabolism. 65(8), 1062-79.
Polyzos, S. A., & Mantzoros C. S. (2016).  Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.. Metabolism. 65(9), 1297-306.
Anastasilakis, A. D., Polyzos S. A., Skouvaklidou E. C., Kynigopoulos G., Saridakis Z. G., Apostolou A., et al. (2016).  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.. Metabolism. 65(10), 1459-65.
Polyzos, S. A., Aronis K. N., Kountouras J., Raptis D. D., Vasiloglou M. F., & Mantzoros C. S. (2016).  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.. Diabetologia. 59(1), 30-43.
Polyzos, S. A., Anastasilakis A. D., Kountouras J., Makras P., Papatheodorou A., Kokkoris P., et al. (2016).  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.. J Bone Miner Metab. 34(4), 447-56.
Polyzos, S. A., & Terpos E. (2016).  Clinical vertebral fractures following denosumab discontinuation.. Endocrine. 54(1), 271-272.
Nikolaidis, N., Polyzos S. A., Giouleme O., Katsinelos P., Eugenidis N., Zeglinas C., et al. (2016).  Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation.. Med Hypotheses. 95, 34.
Mintziori, G., & Polyzos S. A. (2016).  Emerging and future therapies for nonalcoholic steatohepatitis in adults.. Expert Opin Pharmacother. 17(14), 1937-46.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Triantafilli M., et al. (2016).  Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.. Leuk Lymphoma. 57(3), 577-84.
Kountouras, J., Polyzos S. A., Zeglinas C., Katsinelos P., Giorgakis N., Vardaka E., et al. (2016).  Helicobacter pylori infection and oesophageal adenocarcinoma.. Cancer Epidemiol. 42, 206-7.
Polyzos, S. A., & Kountouras J. (2016).  Homocysteine in nonalcoholic steatohepatitis: A reply.. Eur J Intern Med. 35, e40-e41.
Makras, P., Polyzos S. A., & Anastasilakis A. D. (2016).  Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.. J Clin Endocrinol Metab. 101(9), L89-90.
Polyzos, S. A., & Mantzoros C. S. (2016).  Nonalcoholic fatty future disease.. Metabolism. 65(8), 1007-16.
Polyzos, S. A., & Anastasilakis A. D. (2016).  Periostin on the road to nonalcoholic fatty liver disease.. Endocrine. 51(1), 4-6.
Kountouras, J., Polyzos S. A., Gavalas E., Boziki M., Katsinelos P., Zeglinas C., et al. (2016).  A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology.. J Gastrointestin Liver Dis. 25(3), 405-6.
Kountouras, J., Zavos C., Polyzos S. A., & Deretzi G. (2016).  Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration.. Ann Gastroenterol. 29(1), 99.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Kountouras C., Vardaka E., et al. (2016).  Potential molecular aspects of Helicobacter pylori-related hyperplastic polyp development and progression.. Eur J Gastroenterol Hepatol. 28(7), 851-2.
Tsirona, S., Katsaros F., Bargiota A., Polyzos S. A., Arapoglou G., & Koukoulis G. N. (2016).  Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population.. Hormones (Athens). 15(1), 88-98.
Pazaitou-Panayiotou, K., Panagiotou G., Polyzos S. A., & Mantzoros C. S. (2016).  SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR.. Endocr Pract. 22(1), 68-75.
Polyzos, S. A., Kountouras J., Polymerou V., Papadimitriou K. G., Zavos C., & Katsinelos P. (2016).   Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 15(5), 705-14.
2015
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Margouta A., & Mantzoros C. S. (2015).  Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease.. Endocrine. 49(2), 560-2.
Kountouras, J., Zavos C., Polyzos S. A., Katsinelos P., & Deretzi G. (2015).  Association between cirrhosis and Helicobacter pylori-related brain pathologies.. Eur J Gastroenterol Hepatol. 27(2), 183.
Efstathiadou, Z. A., Sakka C., Polyzos S. A., Goutou M., Stakias N., Bargiota A., et al. (2015).  Associations of estrogen receptor alpha and Beta gene polymorphisms with lipid levels and insulin resistance in men.. Metabolism. 64(5), 611-7.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.